Ferring MedicalCONNECT

Male Infertility : Urological Aspects

[…]

Read More… from Male Infertility : Urological Aspects

Research and Publication

[…]

Read More… from Research and Publication

HFEA: Update on Treatment Add-ons Rating System

[…]

Read More… from HFEA: Update on Treatment Add-ons Rating System

ESHRE 2024: most impactful sessions (Audio download)

Expert insights on the most impactful sessions at ESHRE 2024 […]

Read More… from ESHRE 2024: most impactful sessions (Audio download)

ESHRE 2024: Future research trajectories (Audio download)

[…]

Read More… from ESHRE 2024: Future research trajectories (Audio download)

ESHRE 2024: Future research trajectories

[…]

Read More… from ESHRE 2024: Future research trajectories

ESHRE 2024: Significant recurring themes occurring at congresses (Audio download)

[…]

Read More… from ESHRE 2024: Significant recurring themes occurring at congresses (Audio download)

ESHRE 2024: Significant recurring themes

[…]

Read More… from ESHRE 2024: Significant recurring themes

RIF – is PGT-A and hCG all that ESHRE propose?

[…]

Read More… from RIF – is PGT-A and hCG all that ESHRE propose?

Everything you wanted to know about sperm (but were afraid to ask)

[…]

Read More… from Everything you wanted to know about sperm (but were afraid to ask)

Reporting an adverse event

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Ferring Pharmaceuticals Ltd.

General enquiries

Please call or email us on

External funding requests

Please click on the link and complete the form